Misplaced Pages

BCG vaccine

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
#668331

141-750: The Bacillus Calmette–Guérin ( BCG ) vaccine is a vaccine primarily used against tuberculosis (TB). It is named after its inventors Albert Calmette and Camille Guérin . In countries where tuberculosis or leprosy is common, one dose is recommended in healthy babies as soon after birth as possible. In areas where tuberculosis is not common, only children at high risk are typically immunized, while suspected cases of tuberculosis are individually tested for and treated. Adults who do not have tuberculosis and have not been previously immunized, but are frequently exposed, may be immunized, as well. BCG also has some effectiveness against Buruli ulcer infection and other nontuberculous mycobacterial infections. Additionally, it

282-410: A cisplatin -containing drug combination (gemcitabine plus cisplatin; or methotrexate , vinblastine, doxorubicin , and cisplatin) improves survival an addition 5 to 10%. Those with certain types of lower-risk disease may instead receive bladder-sparing therapy. People with just a single tumor at the back of the bladder can undergo partial cystectomy , with the tumor and surrounding area removed, and

423-569: A "new WHO prequalified vaccine" the total supply will be "sufficient to meet both suppressed 2015 demand carried over to 2016, as well as total forecast demand through 2016–2018." In 2011, the Sanofi Pasteur plant flooded, causing problems with mold. The facility, located in Toronto, Ontario, Canada, produced BCG vaccine products made with substrain Connaught such as a tuberculosis vaccine and ImmuCYST,

564-456: A 10–11-year study of 657,461 children found that the MMR vaccine does not cause autism and actually reduced the risk of autism by seven percent. Beside the active vaccine itself, the following excipients and residual manufacturing compounds are present or may be present in vaccine preparations: Various fairly standardized abbreviations for vaccine names have developed, although the standardization

705-477: A BCG immunotherapeutic and bladder cancer drug. By April 2012 the FDA had found dozens of documented problems with sterility at the plant including mold, nesting birds and rusted electrical conduits. The resulting closure of the plant for over two years caused shortages of bladder cancer and tuberculosis vaccines. On 29 October 2014 Health Canada gave the permission for Sanofi to resume production of BCG. A 2018 analysis of

846-529: A French physician and bacteriologist, and his assistant and later colleague, Camille Guérin , a veterinarian, were working at the Institut Pasteur de Lille ( Lille , France) in 1908. Their work included subculturing virulent strains of the tuberculosis bacillus and testing different culture media. They noted a glycerin-bile-potato mixture grew bacilli that seemed less virulent, and changed the course of their research to see if repeated subculturing would produce

987-435: A broad immune response. Although most attenuated vaccines are viral, some are bacterial in nature. Examples include the viral diseases yellow fever , measles , mumps , and rubella , and the bacterial disease typhoid . The live Mycobacterium tuberculosis vaccine developed by Calmette and Guérin is not made of a contagious strain but contains a virulently modified strain called " BCG " used to elicit an immune response to

1128-550: A complete clinical cycle of development and trials proves the vaccine is safe and has long-term effectiveness, following scientific review by a multinational or national regulatory organization, such as the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA). Upon developing countries adopting WHO guidelines for vaccine development and licensure, each country has its own responsibility to issue

1269-486: A device up the urethra in a process called "transurethral resection of bladder tumor" (TURBT). All tumors are removed, as well as a piece of the underlying bladder muscle. Removed tissue is examined by a pathologist to determine if it is cancerous. If the tumor is removed incompletely, or is determined to be particularly high risk, a repeat TURBT is performed 4 to 6 weeks later to detect and remove any additional tumors. Bladder tumors are classified by their appearance under

1410-504: A duration of 15 years; however, its protective effect appears to vary according to geography and the lab in which the vaccine strain was grown. A number of different companies make BCG, sometimes using different genetic strains of the bacterium. This may result in different product characteristics. OncoTICE, used for bladder instillation for bladder cancer, was developed by Organon Laboratories (since acquired by Schering-Plough , and in turn acquired by Merck & Co. ). A similar application

1551-417: A favorable outcome (5-year survival is 95% vs. 69% of muscle invasive bladder cancer). However, 70% of them will have a recurrence after initial treatment with 30% of them presenting with muscle invasive disease. Recurrence and progression to a higher disease stage have a less favorable outcome. Survival after radical cystectomy and pelvic lymph node dissection is dependent on the pathological stage. If

SECTION 10

#1733086195669

1692-415: A given immune reaction. In some cases vaccines may result in partial immune protection (in which immunity is less than 100% effective but still reduces risk of infection) or in temporary immune protection (in which immunity wanes over time) rather than full or permanent immunity. They can still raise the reinfection threshold for the population as a whole and make a substantial impact. They can also mitigate

1833-505: A high incidence of tuberculosis and/or high leprosy burden. This is a partial list of historic and active BCG practice around the globe. A complete atlas of past and present practice has been generated. As of 2022, 155 countries offer the BCG vaccine in their schedule. BCG is prepared from a strain of the attenuated ( virulence -reduced) live bovine tuberculosis bacillus, Mycobacterium bovis , that has lost its ability to cause disease in humans. It

1974-411: A high risk for getting diagnosed with a psychiatric illness post-treatment. People with psychiatric illness post treatment seem to have worse cancer specific and overall survival. Around 500,000 people are diagnosed with bladder cancer each year, and 200,000 die of the disease. This makes bladder cancer the tenth most commonly diagnosed cancer, and the thirteenth cause of cancer deaths. Bladder cancer

2115-569: A median survival of 3–6 months without chemotherapy. Cisplatin -based chemotherapy has increased the median survival to 15-months. However, the 5-year survival is still 15%. There are several prognostic factors which determine cancer specific survival after radical cystectomy. Factor with detrimental effect of cancer specific survival are old age, higher tumor grade and pathological stage, lymph node metastasis , presence of lymphovascular invasion and positive soft tissue margin. Lymph node density (positive lymph nodes/total lymph nodes observed in

2256-507: A national licensure, and to manage, deploy, and monitor the vaccine throughout its use in each nation. Building trust and acceptance of a licensed vaccine among the public is a task of communication by governments and healthcare personnel to ensure a vaccination campaign proceeds smoothly, saves lives, and enables economic recovery. When a vaccine is licensed, it will initially be in limited supply due to variable manufacturing, distribution, and logistical factors, requiring an allocation plan for

2397-594: A parent or sibling with the disease. The exception is in families with Lynch syndrome or Cowden disease , which have increased risk of developing several cancers, including bladder cancer. Large population studies have identified several gene variants that each slightly increase bladder cancer risk. Most of these are variants in genes involved in metabolism of carcinogens ( NAT2 , GSTM1 , and UGT1A6 ), controlling cell growth ( TP63 , CCNE1 , MYC , and FGFR3 ), or repairing DNA damage ( NBN , XRCC1 and 3 , and ERCC2 , 4 , and 5 ). Several studies have examined

2538-460: A particular infectious or malignant disease. The safety and effectiveness of vaccines has been widely studied and verified. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and recognize further and destroy any of

2679-545: A physical examination that can involve a digital rectal exam and pelvic exam , where a doctor feels the pelvic area for unusual masses that could be tumors. Severe bladder tumors often shed cells into the urine; these can be detected by urine cytology , where cells are collected from a urine sample, and viewed under a microscope . Cytology can detect around two thirds of high-grade tumors, but detects just 1 in 8 low-grade tumors. Additional urine tests can be used to detect molecules associated with bladder cancer. Some detect

2820-529: A poorer prognosis. This difference in outcomes is attributed to numerous factors such as, difference in carcinogen exposure, genetics , social and quality of care. One of the common signs of bladder cancer is hematuria and is quite often misdiagnosed as urinary tract infection in women, leading to a delay in diagnosis. Smoking can only partially explain this higher rates in men in western hemisphere. In Africa , men are more prone to do field work and are exposed to infection with Schistosoma , this may explain to

2961-416: A protective effect, the data are inconsistent. The MRC study showed protection waned to 59% after 15 years and to zero after 20 years; however, a study looking at Native Americans immunized in the 1930s found evidence of protection even 60 years after immunization, with only a slight waning in efficacy. BCG seems to have its greatest effect in preventing miliary tuberculosis or tuberculosis meningitis, so it

SECTION 20

#1733086195669

3102-521: A soft catheter. BCG immunization generally causes some pain and scarring at the site of injection. The main adverse effects are keloids —large, raised scars. The insertion to the deltoid muscle is most frequently used because the local complication rate is smallest when that site is used. Nonetheless, the buttock is an alternative site of administration because it provides better cosmetic outcomes. BCG vaccine should be given intradermally. If given subcutaneously, it may induce local infection and spread to

3243-504: A strain that was attenuated enough to be considered for use as a vaccine. The BCG strain was isolated after subculturing 239 times during 13 years from virulent strain on glycerine potato medium. The research continued throughout World War I until 1919, when the now avirulent bacilli were unable to cause tuberculosis disease in research animals. Calmette and Guerin transferred to the Paris Pasteur Institute in 1919. The BCG vaccine

3384-400: A strong immune response. When two or more vaccines are mixed in the same formulation, the two vaccines can interfere. This most frequently occurs with live attenuated vaccines, where one of the vaccine components is more robust than the others and suppresses the growth and immune response to the other components. This phenomenon was first noted in the trivalent Sabin polio vaccine , where

3525-426: A tumor that has not spread; M1 to one that has. The TNM scores are combined to determine the cancer case's stage on a scale of 0 to 4, with a higher stage representing a more extensive cancer with a poorer prognosis. Around 75% of cases are confined to the bladder at the time of diagnosis (T scores: Tis, Ta, or T1), and are called non-muscle-invasive bladder cancer (NMIBC). Around 18% have tumors that have spread into

3666-523: Is transitional cell carcinoma . Other types include squamous cell carcinoma and adenocarcinoma . Diagnosis is typically by cystoscopy with tissue biopsies . Staging of the cancer is determined by transurethral resection of the bladder tumor (TURBT) and medical imaging . Treatment depends on the stage of the cancer . It may include some combination of surgery, radiation therapy, chemotherapy , or immunotherapy . Surgical options may include transurethral resection, partial or complete removal of

3807-519: Is a contraindication to BCG due to the risk of severe local inflammation and scarring; it does not indicate any immunity. BCG is also contraindicated in certain people who have IL-12 receptor pathway defects. BCG is given as a single intradermal injection at the insertion of the deltoid . If BCG is accidentally given subcutaneously , then a local abscess may form (a "BCG-oma") that can sometimes ulcerate, and may require treatment with antibiotics immediately, otherwise without treatment it could spread

3948-537: Is a novel type of vaccine which is composed of the nucleic acid RNA, packaged within a vector such as lipid nanoparticles . Among the COVID-19 vaccines are a number of RNA vaccines to combat the COVID-19 pandemic and some have been approved or have received emergency use authorization in some countries. For example, the Pfizer-BioNTech vaccine and Moderna mRNA vaccine are approved for use in adults and children in

4089-859: Is also commonly linked to bladder cancer risk. Chronic bladder infections can increase one's risk of developing bladder cancer. Most prominent is schistosomiasis , in which the eggs of the flatworm Schistosoma haematobium can become lodged in the bladder wall, causing chronic bladder inflammation and repeated bladder infections. In places with endemic schistosomiasis, up to 16% of bladder cancer cases are caused by prior Schistosoma infection. Worms can be cleared by treatment with praziquantel , which reduces bladder cancer cases in schistosomiasis endemic areas. Similarly, those with long-term indwelling catheters are at risk for repeated urinary tract infections, and have increased risk of developing bladder cancer. Some medical treatments are also known to increase bladder cancer risk. As many as 16% of those treated with

4230-462: Is also imaged for tumors that could cause blood in the urine. This is typically done by injecting a dye into the blood that the kidneys will filter into the urinary tract, then imaging by computed tomography scanning . Those whose kidneys are not functioning well enough to filter the dye may instead be scanned by magnetic resonance imaging . Alternatively, the upper urinary tract can be imaged with ultrasound. Suspected tumors are removed by threading

4371-516: Is at the CDC's page called "Vaccine Acronyms and Abbreviations", with abbreviations used on U.S. immunization records. The United States Adopted Name system has some conventions for the word order of vaccine names, placing head nouns first and adjectives postpositively . This is why the USAN for " OPV " is "poliovirus vaccine live oral" rather than "oral poliovirus vaccine". A vaccine licensure occurs after

BCG vaccine - Misplaced Pages Continue

4512-494: Is by no means centralized or global. For example, the vaccine names used in the United States have well-established abbreviations that are also widely known and used elsewhere. An extensive list of them provided in a sortable table and freely accessible is available at a US Centers for Disease Control and Prevention web page. The page explains that "The abbreviations [in] this table (Column 3) were standardized jointly by staff of

4653-440: Is called herd immunity . Polio, which is transmitted only among humans, is targeted by an extensive eradication campaign that has seen endemic polio restricted to only parts of three countries (Afghanistan, Nigeria, and Pakistan). However, the difficulty of reaching all children, cultural misunderstandings, and disinformation have caused the anticipated eradication date to be missed several times. Vaccines also help prevent

4794-527: Is called vaccination . Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the restriction of diseases such as polio , measles , and tetanus from much of the world. The World Health Organization (WHO) reports that licensed vaccines are currently available for twenty-five different preventable infections . The first recorded use of inoculation to prevent smallpox occurred in

4935-912: Is combination treatment with the chemotherapy drugs cisplatin and gemcitabine . The average person on this combination survives around a year, though 15% experience remission, with survival over five years. Around half of those with metastatic bladder cancer are in too poor health to receive cisplatin. They instead receive the related drug carboplatin along with gemcitabine; the average person on this regimen survives around 9 months. Those whose disease responds to chemotherapy benefit from switching to immune checkpoint inhibitors pembrolizumab or atezolizumab ("Tecentriq") for long-term maintenance therapy . Immune checkpoint inhibitors are also commonly given to those whose tumors do not respond to chemotherapy, as well as those in too poor health to receive chemotherapy. Those whose tumors continue to grow after platinum chemotherapy and immune checkpoint inhibitors can receive

5076-1202: Is common in bladder cancer. Low grade cancer are known to harbor mutations in RAS pathway and the fibroblast growth factor receptor 3 (FGFR3) gene, both of which play a role in the MAPK/ERK pathway . p53 and RB gene mutations are implicated in high-grade muscle invasive tumors. Eighty nine percent of muscle invasive cancers have mutations in chromatin remodeling and histone modifying genes. Muscle invasive bladder cancer are heterogeneous in nature. In general, they can be genetically classified into basal and luminal subtypes. Basal subtype show alterations involving RB and NFE2L2 and luminal type show changes in FGFR3 and KDM6A genes. Basal subtype are subdivided into basal and claudin low-type group and are aggressive and show metastasis at presentation, however they respond to platinum based chemotherapy. Luminal subtype can be subdivided into p53-like and luminal. p53-like tumors of luminal subtype although not as aggressive as basal type, show resistance to chemotherapy People with non-muscle invasive tumors have

5217-454: Is designed to immunize against a single antigen or single microorganism. A multivalent or polyvalent vaccine is designed to immunize against two or more strains of the same microorganism, or against two or more microorganisms. The valency of a multivalent vaccine may be denoted with a Greek or Latin prefix (e.g., bivalent , trivalent , or tetravalent/quadrivalent ). In certain cases, a monovalent vaccine may be preferable for rapidly developing

5358-524: Is encountered, the body recognizes the protein coat on the agent, and thus is prepared to respond, by first neutralizing the target agent before it can enter cells, and secondly by recognizing and destroying infected cells before that agent can multiply to vast numbers. Limitations to their effectiveness, nevertheless, exist. Sometimes, protection fails for vaccine-related reasons such as failures in vaccine attenuation, vaccination regimens or administration. Failure may also occur for host-related reasons if

5499-522: Is for vaccination against tuberculosis . BCG vaccine can be administered after birth intradermally. BCG vaccination can cause a false positive Mantoux test . The most controversial aspect of BCG is the variable efficacy found in different clinical trials, which appears to depend on geography. Trials conducted in the UK have consistently shown a protective effect of 60 to 80%, but those conducted elsewhere have shown no protective effect, and efficacy appears to fall

5640-422: Is frequent, the involvement of other organs is very uncommon. When systemic involvement occurs, liver and lungs are the first organs to be affected (1 week [median] after the last BCG instillation). If BCG is accidentally given to an immunocompromised patient (e.g., an infant with severe combined immune deficiency ), it can cause disseminated or life-threatening infection. The documented incidence of this happening

5781-494: Is less than one per million immunizations given. In 2007, the WHO stopped recommending BCG for infants with HIV , even if the risk of exposure to tuberculosis is high, because of the risk of disseminated BCG infection (which is roughly 400 per 100,000 in that higher risk context). The age of the person and the frequency with which BCG is given has always varied from country to country. The WHO recommends childhood BCG for all countries with

BCG vaccine - Misplaced Pages Continue

5922-510: Is more beneficial to society than vaccinating against a condition that is relatively rare). Other names include "Vaccin Bilié de Calmette et Guérin vaccine" and "Bacille de Calmette et Guérin vaccine". Tentative evidence exists for a beneficial non-specific effect of BCG vaccination on overall mortality in low income countries, or for its reducing other health problems including sepsis and respiratory infections when given early, with greater benefit

6063-524: Is more effective against bacteria, has a better shelf-life, and improves vaccine stability, potency, and safety; but, in the U.S., the European Union , and a few other affluent countries, it is no longer used as a preservative in childhood vaccines, as a precautionary measure due to its mercury content. Although controversial claims have been made that thiomersal contributes to autism , no convincing scientific evidence supports these claims. Furthermore,

6204-507: Is most common in wealthier regions of the world, where exposure to certain carcinogens is highest. It is also common in places where schistosome infection is common, such as North Africa. Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. This makes bladder cancer the sixth most common cancer in men, and the seventeenth in women. When women are diagnosed with bladder cancer, they tend to have more advanced disease and consequently

6345-536: Is most sensitive to papillary tumors (tumors with a finger-like shape that grow into the urine-holding part of the bladder); it is less sensitive to small, low-lying carcinoma in situ (CIS). CIS detection is improved by blue light cystoscopy , where a dye ( hexaminolevulinate ) that accumulates in cancer cells is injected into the bladder during cystoscopy. The dye fluoresces when the cystoscope shines blue light on it, allowing for more sensitive detection of small tumors. The upper urinary tract ( ureters and kidney )

6486-441: Is primarily treated by surgically removing all tumors by TURBT in the same procedure used to collect biopsy tissue for diagnosis. For those with a relatively low risk of tumors recurring, a single dose of chemotherapy ( mitomycin C , epirubicin , or gemcitabine ) injected into the bladder within 24 hours of TURBT reduces the risk of tumor occurrence by about 39%. Those with higher risk are instead treated with bladder injections of

6627-539: Is rarely associated with complications in immunodeficient individuals, and rotavirus vaccines are moderately associated with intussusception . At least 19 countries have no-fault compensation programs to provide compensation for those with severe adverse effects of vaccination. The United States' program is known as the National Childhood Vaccine Injury Act , and the United Kingdom employs

6768-491: Is sometimes used as part of the treatment of bladder cancer . Rates of protection against tuberculosis infection vary widely and protection lasts up to 20 years. Among children, it prevents about 20% from getting infected and among those who do get infected, it protects half from developing disease. The vaccine is given by injection into the skin. No evidence shows that additional doses are beneficial. Serious side effects are rare. Often, redness, swelling, and mild pain occur at

6909-469: Is specially subcultured in a culture medium, usually Middlebrook 7H9 . Because the living bacilli evolve to make the best use of available nutrients, they become less well-adapted to human blood and can no longer induce disease when introduced into a human host. Still, they are similar enough to their wild ancestors to provide some degree of immunity against human tuberculosis. The BCG vaccine can be anywhere from 0 to 80% effective in preventing tuberculosis for

7050-576: Is still extensively used even in countries where efficacy against pulmonary tuberculosis is negligible. The 100th anniversary of the BCG vaccine was in 2021. It remains the only vaccine licensed against tuberculosis, which is an ongoing pandemic . Tuberculosis elimination is a goal of the World Health Organization (WHO), although the development of new vaccines with greater efficacy against adult pulmonary tuberculosis may be needed to make substantial progress. A number of possible reasons for

7191-771: Is the product of Onko BCG of the Polish company Biomed-Lublin , which owns the Brazilian substrain M. bovis BCG Moreau which is less reactogenic than vaccines including other BCG strains. Pacis BCG, made from the Montréal (Institut Armand-Frappier) strain, was first marketed by Urocor in about 2002. Urocor was since acquired by Dianon Systems. Evans Vaccines (a subsidiary of PowderJect Pharmaceuticals ). Statens Serum Institut in Denmark has marketed BCG vaccine prepared using Danish strain 1331. The production of BCG Danish strain 1331 and its distribution

SECTION 50

#1733086195669

7332-462: Is the subunit vaccine against hepatitis   B , which is composed of only the surface proteins of the virus (previously extracted from the blood serum of chronically infected patients but now produced by recombination of the viral genes into yeast ). Other examples include the Gardasil virus-like particle human papillomavirus (HPV) vaccine, the hemagglutinin and neuraminidase subunits of

7473-479: Is used in Europe, while paclitaxel , docetaxel , and pemetrexed are used in the United States; only a minority of those treated improve on these therapies. People with bone metastasis should receive bisphosphonates or denosumab to prevent skeletal related events (e.g. fractures , spinal cord compression , bone pain). Contrast enhanced CT is used to monitor lung, liver, and lymph node metastases. A bone scan

7614-651: Is used to detect and monitor bone metastasis. Treatment response is measured using the Response evaluation criteria in solid tumors ( RECIST ) into one of the following groups; response (complete or partial), stable disease and progressive disease. Bladder cancer is caused by changes to the DNA of bladder cells that result in those cells growing uncontrollably. These changes can be random, or can be induced by exposure to toxic substances such as those from consuming tobacco. Genetic damage accumulates over many years, eventually disrupting

7755-496: Is very efficacious against tuberculous meningitis in the pediatric age group, but its efficacy against pulmonary tuberculosis appears to be variable. Some countries have removed the BCG vaccine from routine vaccination. Two countries that have never used it routinely are the United States and the Netherlands (in both countries, it is felt that having a reliable Mantoux test and therefore being able to accurately detect active disease

7896-484: The American Joint Committee on Cancer . A tumor is assigned three scores based on the extent of the primary tumor (T), its spread to nearby lymph nodes (N), and metastasis to distant sites (M). The T score represents the extent of the original tumor: Ta or Tis for tumors that are confined to the innermost layer of the bladder; T1 for tumors that extend into the bladder's connective tissue; T2 for extension into

8037-459: The BCG vaccine (a live bacterial vaccine, traditionally used for tuberculosis ), administered weekly for six weeks. This nearly halves the rate of tumor recurrence. Recurrence risk is further reduced by a series of "maintenance" BCG injections, given regularly for at least a year. Those whose tumors recur may receive a second round of BCG injections. Tumors that do not respond to BCG may be treated with

8178-458: The League of Nations (predecessor to the World Health Organization (WHO)). Because of opposition, however, it only became widely used after World War II. From 1945 to 1948, relief organizations (International Tuberculosis Campaign or Joint Enterprises) vaccinated over eight million babies in eastern Europe and prevented the predicted typical increase of tuberculosis after a major war. The BCG vaccine

8319-641: The Vaccine Damage Payment . Vaccines typically contain attenuated, inactivated or dead organisms or purified products derived from them. There are several types of vaccines in use. These represent different strategies used to try to reduce the risk of illness while retaining the ability to induce a beneficial immune response. Some vaccines contain live, attenuated microorganisms. Many of these are active viruses that have been cultivated under conditions that disable their virulent properties, or that use closely related but less dangerous organisms to produce

8460-579: The antibody drug conjugate enfortumab vedotin ("Padcev", targets tumor cells with the protein nectin-4 ). Enfortumab vedotin in combination with pembrolizumab can also be used as a first-line therapy in place of chemotherapy. Those with genetic alterations that activate the proteins FGFR2 or FGFR3 (around 20% of those with metastatic bladder cancer) can also benefit from the FGFR inhibitor erdafitinib ("Balversa"). Bladder cancer that continues growing can be treated with second-line chemotherapies. Vinflunine

8601-407: The ileum (part of the small intestine) is removed and used to transport urine from the ureters to a new surgical opening ( stoma ) in the abdomen. Urine drains passively into an ostomy bag worn outside the body, which can be emptied regularly by the wearer. Alternatively, one can have a continent urinary diversion , where the ureters are attached to a piece of ileum that includes the valve between

SECTION 60

#1733086195669

8742-845: The influenza virus, and edible algae vaccines . A subunit vaccine is being used for plague immunization. Certain bacteria have a polysaccharide outer coat that is poorly immunogenic . By linking these outer coats to proteins (e.g., toxins), the immune system can be led to recognize the polysaccharide as if it were a protein antigen. This approach is used in the Haemophilus influenzae type B vaccine . Outer membrane vesicles (OMVs) are naturally immunogenic and can be manipulated to produce potent vaccines. The best known OMV vaccines are those developed for serotype B meningococcal disease . Heterologous vaccines also known as "Jennerian vaccines", are vaccines that are pathogens of other animals that either do not cause disease or cause mild disease in

8883-452: The 16th century in China, with the earliest hints of the practice in China coming during the 10th century. It was also the first disease for which a vaccine was produced. The folk practice of inoculation against smallpox was brought from Turkey to Britain in 1721 by Lady Mary Wortley Montagu . The terms vaccine and vaccination are derived from Variolae vaccinae (smallpox of the cow),

9024-504: The 18th century, scientists thought to find a corollary in tuberculosis by drawing a parallel between bovine tuberculosis and cowpox : it was hypothesized that infection with bovine tuberculosis might protect against infection with human tuberculosis. In the late 19th century, clinical trials using M. bovis were conducted in Italy with disastrous results, because M. bovis was found to be just as virulent as M. tuberculosis . Albert Calmette ,

9165-415: The BCG vaccine may provide protection against COVID-19. However, epidemiologic observations in this respect are ambiguous. The WHO does not recommend its use for prevention as of 12 January 2021. As of January 2021, 20 BCG trials are in various clinical stages. As of October 2022, the results are extremely mixed. A 15-month trial involving people thrice-vaccinated over the two years before

9306-518: The CDC further explains that "Upper-case letters in these abbreviations denote full-strength doses of diphtheria (D) and tetanus (T) toxoids and pertussis (P) vaccine. Lower-case "d" and "p" denote reduced doses of diphtheria and pertussis used in the adolescent/adult-formulations. The 'a' in DTaP and Tdap stands for 'acellular', meaning that the pertussis component contains only a part of the pertussis organism." Another list of established vaccine abbreviations

9447-701: The Centers for Disease Control and Prevention, ACIP Work Groups, the editor of the Morbidity and Mortality Weekly Report (MMWR), the editor of Epidemiology and Prevention of Vaccine-Preventable Diseases (the Pink Book), ACIP members, and liaison organizations to the ACIP." Some examples are " DTaP " for diphtheria and tetanus toxoids and acellular pertussis vaccine, "DT" for diphtheria and tetanus toxoids, and "Td" for tetanus and diphtheria toxoids. At its page on tetanus vaccination,

9588-486: The US. A DNA vaccine uses a DNA plasmid (pDNA)) that encodes for an antigenic protein originating from the pathogen upon which the vaccine will be targeted. pDNA is inexpensive, stable, and relatively safe, making it an excellent option for vaccine delivery. This approach offers a number of potential advantages over traditional approaches, including the stimulation of both B- and T-cell responses, improved vaccine stability,

9729-403: The abscess will generally heal on its own in a matter of weeks. The characteristic raised scar that BCG immunization leaves is often used as proof of prior immunization. This scar must be distinguished from that of smallpox vaccination , which it may resemble. When given for bladder cancer, the vaccine is not injected through the skin, but is instilled into the bladder through the urethra using

9870-469: The absence of any infectious agent and the relative ease of large-scale manufacture. Many innovative vaccines are also in development and use. While most vaccines are created using inactivated or attenuated compounds from microorganisms, synthetic vaccines are composed mainly or wholly of synthetic peptides, carbohydrates, or antigens. Vaccines may be monovalent (also called univalent ) or multivalent (also called polyvalent ). A monovalent vaccine

10011-464: The airflow from blowing out the powder. Then the powder has to be diluted with saline water before injecting. The history of BCG is tied to that of smallpox . By 1865 Jean Antoine Villemin had demonstrated that rabbits could be infected with tuberculosis from humans; by 1868 he had found that rabbits could be infected with tuberculosis from cows, and that rabbits could be infected with tuberculosis from other rabbits. Thus, he concluded that tuberculosis

10152-400: The alternative immune stimulants nadofaragene firadenovec (sold as "Adstiladrin", a gene therapy that makes bladder cells produce an immunostimulant protein), nogapendekin alfa inbakicept ("Anktiva", a combination of immunostimulant proteins), or pembrolizumab ("Keytruda", an immune checkpoint inhibitor ). People whose tumors continue to grow are often treated with surgery to remove

10293-475: The amount of serotype   2 virus in the vaccine had to be reduced to stop it from interfering with the "take" of the serotype   1 and   3 viruses in the vaccine. It was also noted in a 2001 study to be a problem with dengue vaccines, where the DEN-3 serotype was found to predominate and suppress the response to DEN-1, -2 and -4 serotypes. Vaccines typically contain one or more adjuvants , used to boost

10434-399: The bladder and surrounding organs, called radical cystectomy . The bladder, several adjacent lymph nodes , the lower ureters , and nearby genital organs – in men the prostate and seminal vesicles ; in women the uterus and part of the vaginal wall – are all removed. Surgeons construct a new way for urine to leave the body. The most common method is by ileal conduit , where a piece of

10575-452: The bladder at the time of diagnosis. Bladder cancer most commonly spreads to the bones, lungs, liver, and nearby lymph nodes ; tumors cause different symptoms in each location. People whose cancer has metastasized to the bones most often experience bone pain or bone weakness that increases the risk of fractures . Lung tumors can cause persistent cough, coughing up blood , breathlessness, or recurrent chest infections. Cancer that has spread to

10716-426: The bladder muscle (T2, T3, or T4), and are called muscle-invasive bladder cancer (MIBC). Around 3% have tumors that have spread to organs far from the bladder, and are called metastatic bladder cancer. Those with more extensive tumor spread tend to have a poorer prognosis. The treatment of bladder cancer depends on the tumor's shape, size, and location, as well as the affected person's health and preferences. NMIBC

10857-467: The bladder muscle) or small-cell cancer (from neuroendocrine cells ), both of which are relatively rare. The pathologist also grades the tumor sample based on how distinct the cancerous cells look from healthy cells. Bladder cancer is divided into either low-grade (more similar to healthy cells) or high-grade (less similar). Each bladder cancer case is assigned a stage based on the TNM system defined by

10998-668: The bladder repaired. Those with no CIS or urinary blockage may undergo TURBT to remove visible tumors, followed by chemotherapy and radiotherapy ; around two thirds of these people are permanently cured. After treatment, surveillance tests – urine and blood tests, and MRI or CT scans – are done every three to six months to look for evidence that tumors may be recurring. Those who have retained their bladder also receive cystoscopies to look for additional bladder tumors. Recurrent bladder tumors are treated with radical cystectomy. Tumor recurrences elsewhere are treated as metastatic bladder cancer. The standard of care for metastatic bladder cancer

11139-439: The bladder, or urinary diversion . The typical five-year survival rates in the United States is 77%, Canada is 75%, and Europe is 68%. Bladder cancer, as of 2018, affected about 1.6 million people globally with 549,000 new cases and 200,000 deaths. Age of onset is most often between 65 and 84 years of age. Males are more often affected than females, with the lifetime risk in males being 1.1% and 0.27% in females. In 2018,

11280-483: The blood) and lymphangiomatous spread. Regional bone infection (BCG osteomyelitis or osteitis ) and disseminated BCG infection are rare complications of BCG vaccination, but potentially life-threatening. Systemic antituberculous therapy may be helpful in severe complications. When BCG is used for bladder cancer, around 2.9% of treated patients discontinue immunotherapy due to a genitourinary or systemic BCG-related infection, however while symptomatic bladder BCG infection

11421-490: The chemotherapeutic cyclophosphamide go on to develop bladder cancer within 15 years of their treatment. Similarly, those treated with pelvic radiation (typically for prostate or cervical cancer) are at increased risk of developing bladder cancer five to 15 years after treatment. Long-term use of the medication pioglitazone for type 2 diabetes may increase bladder cancer risk. Bladder cancer does not typically run in families; 4% of those diagnosed with bladder cancer have

11562-405: The closer one gets to the equator. A 1994 systematic review found that BCG reduces the risk of getting tuberculosis by about 50%. Differences in effectiveness depend on region, due to factors such as genetic differences in the populations, changes in environment, exposure to other bacterial infections, and conditions in the laboratory where the vaccine is grown, including genetic differences between

11703-891: The death of the affected person. Tobacco smoking is the main contributor to bladder cancer risk; around half of bladder cancer cases are estimated to be caused by smoking. Tobacco contains carcinogenic molecules that enter the blood and are filtered by the kidneys into the urine. There they can cause damage to the DNA of bladder cells, eventually leading to cancer. Bladder cancer risk rises both with number of cigarettes smoked per day, and with duration of smoking habit. Those who smoke also tend to have worse courses of bladder cancer, with an increased risk of treatment failure, metastasis, and death. The risk of developing bladder cancer decreases in those who quit smoking , falling up to 30% after five years of smoking abstention. Cancer risk continues to fall over time with smoking abstention, but never returns to

11844-503: The development of antibiotic resistance. For example, by greatly reducing the incidence of pneumonia caused by Streptococcus pneumoniae , vaccine programs have greatly reduced the prevalence of infections resistant to penicillin or other first-line antibiotics. The measles vaccine is estimated to prevent a million deaths every year. Vaccinations given to children, adolescents, or adults are generally safe. Adverse effects, if any, are generally mild. The rate of side effects depends on

11985-426: The disease has not spread to the lymph node and is limited to the bladder (T1 or T2, N0) the 5-year survival is 78%. If it has spread locally around the region of the bladder with no lymph node involved (T3, N0) then the 5-year survival drops to 47%. In disease with lymph node spread (N+, irrespective of T stage) the 5-year survival is 31%. Locally advanced and metastatic disease drastically decreases survival, with

12126-399: The disease. Some instead have "microscopic haematuria" – small amounts of blood in the urine that can only be seen under a microscope during urinalysis – pain while urinating, or no symptoms at all (their tumors are detected during unrelated medical imaging ). Less commonly, a tumor can block the flow of urine into the bladder, causing pain along the flank of the body (between the ribs and

12267-447: The earlier it is used. In rhesus macaques , BCG shows improved rates of protection when given intravenously . Some risks must be evaluated before it can be translated to humans. The University of Oxford Jenner Institute is conducting a study comparing the efficacy of injected versus inhaled BCG vaccine in already-vaccinated adults. As of 2017, BCG vaccine is in the early stages of being studied in type 1 diabetes (T1D). Use of

12408-425: The eradication of smallpox , one of the most contagious and deadly diseases in humans. Other diseases such as rubella, polio , measles, mumps, chickenpox , and typhoid are nowhere near as common as they were a hundred years ago thanks to widespread vaccination programs. As long as the vast majority of people are vaccinated, it is much more difficult for an outbreak of disease to occur, let alone spread. This effect

12549-416: The finished product, as they may in the environment and population as a whole. Many vaccines need preservatives to prevent serious adverse effects such as Staphylococcus infection, which in one 1928 incident killed 12 of 21 children inoculated with a diphtheria vaccine that lacked a preservative. Several preservatives are available, including thiomersal, phenoxyethanol , and formaldehyde . Thiomersal

12690-541: The general population, a high standard of safety is required. As part of a multinational licensing of a vaccine, the World Health Organization Expert Committee on Biological Standardization developed guidelines of international standards for manufacturing and quality control of vaccines, a process intended as a platform for national regulatory agencies to apply for their own licensing process. Vaccine manufacturers do not receive licensing until

12831-403: The global supply concluded that the supplies are adequate to meet forecast BCG vaccine demand, but that risks of shortages remain, mainly due to dependence of 75 percent of WHO pre-qualified supply on just two suppliers. Some BCG vaccines are freeze dried and become fine powder. Sometimes the powder is sealed with vacuum in a glass ampoule. Such a glass ampoule has to be opened slowly to prevent

12972-561: The highest rate of bladder cancer occurred in Southern and Western Europe followed by North America with rates of 15, 13, and 12 cases per 100,000 people. The highest rates of bladder cancer deaths were seen in Northern Africa and Western Asia followed by Southern Europe. The most common symptom of bladder cancer is visible blood in the urine (haematuria) despite painless urination. This affects around 75% of people eventually diagnosed with

13113-433: The hips). Most people with blood in the urine do not have bladder cancer; up to 22% of those with visible haematuria and 5% with microscopic haematuria are diagnosed with the disease. Women with bladder cancer and haematuria are often misdiagnosed with urinary tract infections , delaying appropriate diagnosis and treatment. Around 3% of people with bladder cancer have tumors that have already spread (metastasized) outside

13254-434: The host can still become infected. Once antibodies are produced, they may promote immunity in any of several ways, depending on the class of antibodies involved. Their success in clearing or inactivating a pathogen will depend on the amount of antibodies produced and on the extent to which those antibodies are effective at countering the strain of the pathogen involved, since different strains may be differently susceptible to

13395-414: The host's immune system does not respond adequately or at all. Host-related lack of response occurs in an estimated 2-10% of individuals, due to factors including genetics, immune status, age, health and nutritional status. One type of primary immunodeficiency disorder resulting in genetic failure is X-linked agammaglobulinemia , in which the absence of an enzyme essential for B cell development prevents

13536-411: The host's immune system from generating antibodies to a pathogen . Host–pathogen interactions and responses to infection are dynamic processes involving multiple pathways in the immune system. A host does not develop antibodies instantaneously: while the body's innate immunity may be activated in as little as twelve hours, adaptive immunity can take 1–2 weeks to fully develop. During that time,

13677-417: The immune response. Tetanus toxoid, for instance, is usually adsorbed onto alum . This presents the antigen in such a way as to produce a greater action than the simple aqueous tetanus toxoid. People who have an adverse reaction to adsorbed tetanus toxoid may be given the simple vaccine when the time comes for a booster. In the preparation for the 1990 Persian Gulf campaign, the whole cell pertussis vaccine

13818-430: The immunodominant antigen of the pathogen or a surface protein that enables the formation of neutralizing antibodies. The subgroup of genetic vaccines encompass viral vector vaccines, RNA vaccines and DNA vaccines. Viral vector vaccines use a safe virus to insert pathogen genes in the body to produce specific antigens , such as surface proteins , to stimulate an immune response . An mRNA vaccine (or RNA vaccine )

13959-696: The impact of various lifestyle factors on the risk of developing bladder cancer. A 2018 summary of evidence from the World Cancer Research Fund and American Institute for Cancer Research concluded that there is "limited, suggestive evidence" that consumption of tea, and a diet high in fruits and vegetables reduce a person's risk of developing bladder cancer. They also considered available data on exercise, body fat, and consumption of dairy, red meat, fish, grains, legumes, eggs, fats, soft drinks, alcohol, juices, caffeine, sweeteners, and various vitamins and minerals; for each they found insufficient data to link

14100-413: The infection, causing severe damage to vital organs. An abscess is not always associated with incorrect administration, and it is one of the more common complications that can occur with the vaccination. Numerous medical studies on treatment of these abscesses with antibiotics have been done with varying results, but the consensus is once pus is aspirated and analysed, provided no unusual bacilli are present,

14241-511: The level of those who have never smoked. Because development of bladder cancer takes many years, it is not yet known if use of electronic cigarettes carries the same risk as smoking tobacco; however, those who use electronic cigarettes have higher levels of some urinary carcinogens than those who do not. Up to 10% of bladder cancer cases are caused by workplace exposure to toxic chemicals. Exposure to certain aromatic amines , namely benzidine , beta-naphthylamine , and ortho-toluidine used in

14382-430: The lifestyle factor to bladder cancer risk. Several other studies have indicated a slight increased risk of developing bladder cancer in those who are overweight or obese , as well as a slight decrease in risk for those who undertake high levels of physical activity. Several studies have investigated a link between levels of fluid intake and bladder cancer risk – testing the theory that high fluid intake dilutes toxins in

14523-585: The limited supply and which population segments should be prioritized to first receive the vaccine. Bladder cancer Bladder cancer is any of several types of cancer arising from the tissues of the urinary bladder . Symptoms include blood in the urine , pain with urination , and low back pain. It is caused when epithelial cells that line the bladder become malignant. Risk factors for bladder cancer include smoking , family history, prior pelvic radiation therapy , frequent bladder infections , and exposure to certain chemicals. The most common type

14664-423: The liver can cause general malaise , loss of appetite, weight loss, abdominal pain or swelling , jaundice (yellowing of the skin and eyes), and skin itch. Spread to nearby lymph nodes can cause pain and swelling around the affected lymph nodes, typically in the abdomen or groin. Those suspected of having bladder cancer can undergo several tests to assess the presence and extent of any tumors. First, many undergo

14805-733: The location of the tumors. Tumors on the superolateral bladder wall spread to external iliac lymph nodes . Tumors on the neck, anterior wall and fundus spread commonly to the internal iliac lymph nodes. From the regional lymph nodes (i.e. obturator, internal and external lymph nodes) the cancer spreads to distant sites like the common iliac lymph nodes and paraaortic lymph nodes . Skipped lymph node lesions are not seen in bladder cancer. Mutations in FGFR3 , TP53 , PIK3CA , KDM6A , ARID1A , KMT2D , HRAS , TERT , KRAS , CREBBP , RB1 and TSC1 genes may be associated with some cases of bladder cancer. Deletions of parts or whole of chromosome 9

14946-576: The manufacturers of the vaccine. Dr. R. G. Ferguson , working at the Fort Qu'Appelle Sanatorium in Saskatchewan, was among the pioneers in developing the practice of vaccination against tuberculosis. In Canada, more than 600 children from residential schools were used as involuntary participants in BCG vaccine trials between 1933 and 1945. In 1928, the BCG vaccine was adopted by the Health Committee of

15087-510: The metalworking and dye industries, can increase the risk of bladder cancer in metalworkers, dye producers, painters, printers, hairdressers, and textiles workers. The International Agency for Research on Cancer further classifies rubber processing, aluminum production, and firefighting as occupations that increase one's risk of developing bladder cancer. Exposure to arsenic – either through workplace exposure or through drinking water in places where arsenic naturally contaminates groundwater –

15228-448: The microorganism. Examples of toxoid-based vaccines include tetanus and diphtheria . Not all toxoids are for microorganisms; for example, Crotalus atrox toxoid is used to vaccinate dogs against rattlesnake bites. Rather than introducing an inactivated or attenuated microorganism to an immune system (which would constitute a "whole-agent" vaccine), a subunit vaccine uses a fragment of it to create an immune response. One example

15369-416: The microorganisms associated with that agent that it may encounter in the future. Vaccines can be prophylactic (to prevent or alleviate the effects of a future infection by a natural or "wild" pathogen ), or therapeutic (to fight a disease that has already occurred, such as cancer ). Some vaccines offer full sterilizing immunity , in which infection is prevented. The administration of vaccines

15510-528: The microscope, and by their cell type of origin. Over 90% of bladder tumors arise from the cells that form the bladder's inner lining, called urothelial cells or transitional cells; the tumor is then classified as urothelial cancer or transitional cell cancer . Around 5% of cases are squamous cell cancer (from a rarer cell in the bladder lining), particularly common in places with schistosomiasis . Up to 2% of cases are adenocarcinoma (from mucus -producing gland cells). The remaining cases are sarcomas (from

15651-405: The most successful immunotherapies. BCG vaccine has been the "standard of care for patients with bladder cancer (NMIBC)" since 1977. By 2014 there were more than eight different considered biosimilar agents or strains used for the treatment of nonmuscle-invasive bladder cancer. A pre-injection tuberculin skin test is usually carried out before administering BCG. A reactive tuberculin skin test

15792-416: The muscle; T3 for extension through the muscle into the surrounding fatty tissue; and T4 for extension fully outside the bladder. The N score represents spread to nearby lymph nodes: N0 for no spread; N1 for spread to a single nearby lymph node; N2 for spread to several nearby lymph nodes; N3 for spread to more distant lymph nodes outside the pelvis. The M score designates spread to more distant organs: M0 for

15933-407: The new protective inoculations then being developed. The science of vaccine development and production is termed vaccinology . There is overwhelming scientific consensus that vaccines are a very safe and effective way to fight and eradicate infectious diseases. The immune system recognizes vaccine agents as foreign, destroys them, and "remembers" them. When the virulent version of an agent

16074-404: The normal functioning of bladder cells and causing them to grow uncontrollably into a lump of cells called a tumor. Cancers cells accumulate further DNA changes as they multiply, which can allow the tumor to evade the immune system , resist regular cell death pathways , and eventually spread to distant body sites. The new tumors that form in various organs damage those organs, eventually causing

16215-440: The number of cases dropped to fewer than 150 per year (median of 56). In early 2008, there were 64 suspected cases of measles. Fifty-four of those infections were associated with importation from another country, although only thirteen percent were actually acquired outside the United States; 63 of the 64 individuals either had never been vaccinated against measles or were uncertain whether they had been vaccinated. Vaccines led to

16356-446: The only childhood vaccine in the U.S. that contains thiomersal in greater than trace amounts is the influenza vaccine, which is currently recommended only for children with certain risk factors. Single-dose influenza vaccines supplied in the UK do not list thiomersal in the ingredients. Preservatives may be used at various stages of the production of vaccines, and the most sophisticated methods of measurement might detect traces of them in

16497-400: The organism being treated. The classic example is Jenner's use of cowpox to protect against smallpox. A current example is the use of BCG vaccine made from Mycobacterium bovis to protect against tuberculosis . Genetic vaccines are based on the principle of uptake of a nucleic acid into cells, whereupon a protein is produced according to the nucleic acid template. This protein is usually

16638-457: The pandemic shows positive results in preventing infection in BCG-naive people with type 1 diabetes. On the other hand, a 5-month trial shows that re-vaccinating with BCG does not help prevent infection in healthcare workers. Both of these trials were double-blind randomized controlled trials . Vaccine A vaccine is a biological preparation that provides active acquired immunity to

16779-427: The proteins bladder tumor antigen or NMP22 that tend to be elevated in the urine of those with bladder cancer; some detect mRNA of tumor-associated genes; some use fluorescence microscopy to detect cancerous cells more sensitively than regular cytology. Many also undergo cystoscopy , wherein a flexible camera is threaded up the urethra and into the bladder to visually inspect for cancerous tissue. Cystoscopy

16920-462: The regional lymph nodes , causing either suppurative (production of pus ) and nonsuppurative lymphadenitis . Conservative management is usually adequate for nonsuppurative lymphadenitis. If suppuration occurs, it may need needle aspiration . For nonresolving suppuration, surgical excision may be required. Evidence for the treatment of these complications is scarce. Uncommonly, breast and gluteal abscesses can occur due to haematogenous (carried by

17061-437: The severity of infection and response to a vaccine. Elderly (above age 60), allergen-hypersensitive , and obese people have susceptibility to compromised immunogenicity , which prevents or inhibits vaccine effectiveness, possibly requiring separate vaccine technologies for these specific populations or repetitive booster vaccinations to limit virus transmission . Severe side effects are extremely rare. Varicella vaccine

17202-457: The severity of infection, resulting in a lower mortality rate , lower morbidity , faster recovery from illness, and a wide range of other effects. Those who are older often display less of a response than those who are younger, a pattern known as Immunosenescence . Adjuvants commonly are used to boost immune response, particularly for older people whose immune response to a simple vaccine may have weakened. The efficacy or performance of

17343-406: The site of injection. A small ulcer may also form with some scarring after healing. Side effects are more common and potentially more severe in those with immunosuppression . Although no harmful effects on the fetus have been observed, there is insufficient evidence about the safety of BCG vaccination during pregnancy and therefore the vaccine is not recommended for use during pregnancy. The vaccine

17484-399: The small and large intestine; this valve naturally closes, allowing urine to be retained in the body rather than in an ostomy bag. The affected person empties the new urine reservoir serveral times each day by self-catheterization – passing a narrow tube through the stoma. Some can instead have the piece of ileum attached directly to the urethra, allowing the affected person to urinate through

17625-853: The small intestine can result in reduced vitamin B12 absorption, which can be treated with oral vitamin B12 supplementation. Issues with the new urine system can cause urinary retention, which can damage the ureters and kidneys and increase one's risk of urinary tract infection. Those not well enough or unwilling to undergo radical cystectomy may instead benefit from further bladder injections of chemotherapy – mitomycin C, gemcitabine, docetaxel , or valrubicin – or intravenous injection of pembrolizumab. Around 1 in 5 people with NMIBC will eventually progress to MIBC. Most people with muscle-invasive bladder cancer are treated with radical cystectomy, which cures around half of those affected. Treating with chemotherapy prior to surgery (called " neoadjuvant therapy ") using

17766-746: The specimen from surgery) is a predictor of survival in lymph node positive disease. Higher the density lower is the survival. After radical cystectomy, urinary and sexual function remain inferior to the general population. People who have a neobladder have better emotional function and body image compared with ones with cutaneous diversion (who need to wear a bag to collect urine over their abdomen). Social factors such as family, relationships, health and finances contribute significantly for determining good quality of life in people who have been diagnosed with bladder cancer. A high percentage of people with bladder cancer have anxiety and depression . People who are young, single and have advanced clinical disease have

17907-420: The strains being cultured and the choice of growth medium. A systematic review and meta-analysis conducted in 2014 demonstrated that the BCG vaccine reduced infections by 19–27% and reduced progression to active tuberculosis by 71%. The studies included in this review were limited to those that used interferon gamma release assay . The duration of protection of BCG is not clearly known. In those studies showing

18048-496: The successful conclusion of the development cycle and further the clinical trials and other programs involved through Phases   I–III demonstrating safety, immunoactivity, immunogenetic safety at a given specific dose, proven effectiveness in preventing infection for target populations, and enduring preventive effect (time endurance or need for revaccination must be estimated). Because preventive vaccines are predominantly evaluated in healthy population cohorts and distributed among

18189-454: The surgical wound (15%). Around 25% of those who undergo the surgery end up readmitted to the hospital within 30 days; up to 2% die within 30 days of the surgery. Rerouting the ureters can also cause permanent metabolic issues. The piece of ileum used to reroute urine flow can absorb more ammonium chloride from the urine than the original bladder would, resulting in metabolic acidosis , which can be treated with sodium bicarbonate . Shortening

18330-510: The term devised by Edward Jenner (who both developed the concept of vaccines and created the first vaccine) to denote cowpox . He used the phrase in 1798 for the long title of his Inquiry into the Variolae vaccinae Known as the Cow Pox , in which he described the protective effect of cowpox against smallpox. In 1881, to honor Jenner, Louis Pasteur proposed that the terms should be extended to cover

18471-408: The urethra as they would pre-surgery – although without the original bladder nerves, they will no longer have the urge to urinate when the urine reservoir is full. Radical cystectomy has both immediate and lifelong side effects. It is common for those recovering from surgery to experience gastrointestinal problems (29% of those who underwent radical cystectomy), infections (25%), and other issues with

18612-418: The urine and removes them through the body through more frequent urination – but have had inconsistent results, and a relationship remains unclear. The most common sites for bladder cancer metastases are the lymph nodes, bones, lung, liver, and peritoneum . The most common sentinel lymph nodes draining bladder cancer are obturator and internal iliac lymph nodes . The location of lymphatic spread depends on

18753-574: The vaccine in question. Some common side effects include fever, pain around the injection site, and muscle aches. Additionally, some individuals may be allergic to ingredients in the vaccine. MMR vaccine is rarely associated with febrile seizures . Host-("vaccinee")-related determinants that render a person susceptible to infection, such as genetics , health status (underlying disease, nutrition, pregnancy, sensitivities or allergies ), immune competence , age, and economic impact or cultural environment can be primary or secondary factors affecting

18894-413: The vaccine is dependent on several factors: If a vaccinated individual does develop the disease vaccinated against ( breakthrough infection ), the disease is likely to be less virulent than in unvaccinated cases. Important considerations in an effective vaccination program: In 1958, there were 763,094 cases of measles in the United States; 552 deaths resulted. After the introduction of new vaccines,

19035-772: The vaccine. The live attenuated vaccine containing strain Yersinia pestis EV is used for plague immunization. Attenuated vaccines have some advantages and disadvantages. Attenuated, or live, weakened, vaccines typically provoke more durable immunological responses. But they may not be safe for use in immunocompromised individuals, and on rare occasions mutate to a virulent form and cause disease. Some vaccines contain microorganisms that have been killed or inactivated by physical or chemical means. Examples include IPV ( polio vaccine ), hepatitis A vaccine , rabies vaccine and most influenza vaccines . Toxoid vaccines are made from inactivated toxic compounds that cause illness rather than

19176-443: The variable efficacy of BCG in different countries have been proposed. None has been proven, some have been disproved, and none can explain the lack of efficacy in both low tuberculosis-burden countries (US) and high tuberculosis-burden countries (India). The reasons for variable efficacy have been discussed at length in a WHO document on BCG. BCG has protective effects against some nontuberculosis mycobacteria. BCG has been one of

19317-494: Was first used in humans in 1921. Public acceptance was slow, and the Lübeck disaster , in particular, did much to harm it. Between 1929 and 1933 in Lübeck , 251 infants were vaccinated in the first 10 days of life; 173 developed tuberculosis and 72 died. It was subsequently discovered that the BCG administered there had been contaminated with a virulent strain that was being stored in the same incubator, which led to legal action against

19458-764: Was later undertaken by AJVaccines company since the ownership transfer of SSI's vaccine production business to AJ Vaccines Holding A/S which took place on 16 January 2017. Japan BCG Laboratory markets its vaccine, based on the Tokyo 172 substrain of Pasteur BCG, in 50 countries worldwide. According to a UNICEF report published in December 2015, on BCG vaccine supply security, global demand increased in 2015 from 123 to 152.2 million doses. To improve security and to [diversify] sources of affordable and flexible supply," UNICEF awarded seven new manufacturers contracts to produce BCG. Along with supply availability from existing manufacturers, and

19599-428: Was originally developed from Mycobacterium bovis , which is commonly found in cattle. While it has been weakened, it is still live . The BCG vaccine was first used medically in 1921. It is on the World Health Organization's List of Essential Medicines . As of 2004, the vaccine is given to about 100 million children per year globally. However, it is not commonly administered in the United States. The main use of BCG

19740-445: Was transmitted via some unidentified microorganism (or "virus" , as he called it). In 1882 Robert Koch regarded human and bovine tuberculosis as identical. But in 1895, Theobald Smith presented differences between human and bovine tuberculosis, which he reported to Koch. By 1901 Koch distinguished Mycobacterium bovis from Mycobacterium tuberculosis . Following the success of vaccination in preventing smallpox, established during

19881-448: Was used as an adjuvant for anthrax vaccine. This produces a more rapid immune response than giving only the anthrax vaccine, which is of some benefit if exposure might be imminent. Vaccines may also contain preservatives to prevent contamination with bacteria or fungi . Until recent years, the preservative thiomersal ( a.k.a. Thimerosal in the US and Japan) was used in many vaccines that did not contain live viruses. As of 2005,

#668331